This research contradicts previous concerns about the potential of drugs like Ozempic to trigger suicidal ideation and ...

Participants with type 2 diabetes who stopped insulin after receiving the novel ReCET endoscopic procedure in combination ...

Semaglutide significantly reduces cardiovascular events and adverse effects in overweight and obese patients. The study ...

Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease ...

Semaglutide use was associated with a lower risk for opioid overdose than other antidiabetic medications in comorbid type 2 diabetes and OUD.

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...

Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...

Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that ...

Semaglutide — the active ingredient in Ozempic®, Wegovy®, and Rybelsus® — can reduce your appetite and curb food cravings to ...

Compounded semaglutide is semaglutide with an altered formula to create an unbranded alternative to Wegovy and Ozempic.

An online store has jumped on the Ozempic craze by releasing a “sexy” semaglutide injection costume just in time for ...

每经AI快讯，有投资者在投资者互动平台提问：公司司美格鲁肽项目目前进展怎么样？ 泰恩康（301263.SZ）10月15日在投资者互动平台表示，Semaglutide 司美格鲁肽原液（API）已完成三批生产和检验，第一批产品已出货 (记者 蔡鼎) ...